Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Betimol Generic Name & Formulations
Legal Class
Rx
General Description
Timolol (as hemihydrate) 0.25%, 0.5%; oph. soln; contains benzalkonium chloride.
Pharmacological Class
Noncardioselective beta-blocker.
How Supplied
Soln—5mL, 10mL, 15mL
Manufacturer
Betimol Indications
Indications
Open-angle glaucoma.
Betimol Dosage and Administration
Adult
1 drop twice daily.
Children
Not recommended.
Betimol Contraindications
Contraindications
Overt heart failure. Cardiogenic shock. Sinus bradycardia. 2nd- or 3rd-degree AV block. Asthma. Severe COPD.
Betimol Boxed Warnings
Not Applicable
Betimol Warnings/Precautions
Warnings/Precautions
Discontinue if heart failure develops and prior to surgery. Not for use as sole agent in narrow-angle glaucoma. Avoid abrupt cessation. Cerebrovascular insufficiency. Diabetes. COPD. Bronchospastic disease. May mask signs of hypoglycemia, thyrotoxicosis. Myasthenia gravis. Bacterial keratitis. Measure IOP after 4 wks of treatment. Pregnancy (Cat.C). Nursing mothers: not recommended.
Betimol Pharmacokinetics
See Literature
Betimol Interactions
Interactions
May potentiate systemic β-blockers, reserpine. May cause conduction defects with calcium channel blockers, digitalis. May antagonize β-agonists. May block epinephrine.
Betimol Adverse Reactions
Adverse Reactions
Ocular irritation, eyelid erythema, conjunctival injection, headache, epiphora, photophobia. Systemic β-blocking effects (bradycardia, arrhythmias, hypotension, bronchospasm, heart failure).
Betimol Clinical Trials
See Literature
Betimol Note
Not Applicable
Betimol Patient Counseling
See Literature
